Cite
HARVARD Citation
Zahar, J. et al. (2022). Risk stratification for selecting empiric antibiotherapy during and after COVID-19. Current opinion in infectious diseases. 35 (6), pp. 605-613. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zahar, J. et al. (2022). Risk stratification for selecting empiric antibiotherapy during and after COVID-19. Current opinion in infectious diseases. 35 (6), pp. 605-613. [Online].